8-K
filed July 18, 2024, 7:59 PM ET
CIK 0001850079
debt
confidence high
sentiment neutral
materiality 0.75
Telesis Bio enters $5.85M promissory notes at 12% from major shareholders, repays MidCap debt, expands board
Telesis Bio Inc.
- Issued $5.85M promissory notes to Novalis and Northpond at 12% annual interest, maturing Jan 16, 2026.
- Repaid $5.84M to MidCap Financial, terminating existing term and revolver loan agreements.
- Board expanded from 8 to 13; five new directors appointed: Hlavinka, Golub, Hodges, Weissman, Krueger.
- Side letter gives lenders board control: majority of nominating committee, replacement rights while >10% ownership.
- Registration rights waiver defers liquidated damages and waives accrued interest for a set period.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Sarah Hlavinka was appointed as Director at Telesis Bio Inc..
- Action
- appointed
- Role
- Director
Exact text from the filing
appointed each of Sarah Hlavinka, Steve Golub, Michael Hodges, James Weissman, and Todd Krueger (collectively, the “New Directors”), as members of the Board to fill the five vacancies.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
James Weissman was appointed as Director at Telesis Bio Inc..
- Action
- appointed
- Role
- Director
Exact text from the filing
appointed each of Sarah Hlavinka, Steve Golub, Michael Hodges, James Weissman, and Todd Krueger (collectively, the “New Directors”), as members of the Board to fill the five vacancies.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Todd Krueger was appointed as Director at Telesis Bio Inc..
- Action
- appointed
- Role
- Director
Exact text from the filing
appointed each of Sarah Hlavinka, Steve Golub, Michael Hodges, James Weissman, and Todd Krueger (collectively, the “New Directors”), as members of the Board to fill the five vacancies.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Steve Golub was appointed as Director at Telesis Bio Inc..
- Action
- appointed
- Role
- Director
Exact text from the filing
appointed each of Sarah Hlavinka, Steve Golub, Michael Hodges, James Weissman, and Todd Krueger (collectively, the “New Directors”), as members of the Board to fill the five vacancies.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Michael Hodges was appointed as Director at Telesis Bio Inc..
- Action
- appointed
- Role
- Director
Exact text from the filing
appointed each of Sarah Hlavinka, Steve Golub, Michael Hodges, James Weissman, and Todd Krueger (collectively, the “New Directors”), as members of the Board to fill the five vacancies.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.